Annual Drug Patent Expirations for LUMIFY
Lumify is a drug marketed by Bausch And Lomb Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
Drug patent litigation for LUMIFY.
This drug has thirty-three patent family members in sixteen countries.
The generic ingredient in LUMIFY is brimonidine tartrate. One supplier is listed for this compound. Additional details are available on the brimonidine tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
